Gufic Biosciences Limited (GUFICBIO.NS)

INR 450.25

(0.18%)

Market Cap (In INR)

45.15 Billion

Revenue (In INR)

8.06 Billion

Net Income (In INR)

861.35 Million

Avg. Volume

143.21 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
277.65-504.25
PE
-
EPS
-
Beta Value
0.796
ISIN
INE742B01025
CUSIP
Y28251125
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Pranav Jayesh Choksi
Employee Count
-
Website
https://gufic.com
Ipo Date
2004-10-19
Details
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.